Clinical, social and ethical issues associated with non-invasive prenatal testing for aneuploidy

References

• American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 77: screening for fetal chromosomal abnormalities. Obstet Gynecol 2007;109:217–27.
   PubMedGoogle Scholar
• Nicolaides KH. Screening for fetal aneuploidies at 11 to 13 weeks. Prenat Diagn 2011;31:7–15.
   PubMed Web of Science ®Google Scholar
• Tabor A, Alfirevic Z. Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn Ther 2010;27:1–7.
   PubMed Web of Science ®Google Scholar
• Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485–7.
   PubMed Web of Science ®Google Scholar
• Hyett JA, Gardener G, Stojilkovic-Mikic T, et al. Reduction in diagnostic and therapeutic interventions by non-invasive determination of fetal sex in early pregnancy. Prenat Diagn 2005;25:1111–16.
   PubMed Web of Science ®Google Scholar
• Finning KM, Chitty LS. Non-invasive fetal sex determination: impact on clinical practice. Semin Fetal Neonatal Med 2008;13:69–75.
   PubMed Web of Science ®Google Scholar
• Fan HC, Blumenfeld YJ, Chitkara U, et al. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci U S A 2008;105:16266–71.
   PubMed Web of Science ®Google Scholar
• Lo YM, Chiu RW. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidies by maternal plasma nucleic acid analysis. Clin Chem 2008;54:461–6.
   PubMed Web of Science ®Google Scholar
• Lo YM, Zhang J, Leung TN, et al. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 1999;64:218–24.
   PubMed Web of Science ®Google Scholar
• Chiu RW, Lo YM. Non-invasive prenatal diagnosis by fetal nucleic acid analysis in maternal plasma: the coming of age. Semin Fetal Neonatal Med 2011;16:88–93.
   PubMed Web of Science ®Google Scholar
• Gil MM, Quezada MS, Revello R, et al. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol 2015;45:249–66.
   PubMed Web of Science ®Google Scholar
• Alberry M, Maddocks D, Jones M, et al. Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenat Diagn 2007;27:415–18.
   PubMed Web of Science ®Google Scholar
• Lun FM, Chiu RW, Chan KC, et al. Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma. Clin Chem 2008;54:1664–72.
   PubMed Web of Science ®Google Scholar
• Wang JC, Sahoo T, Schonberg S, et al. Discordant noninvasive prenatal testing and cytogenetic results: a study of 109 consecutive cases. Genet Med 2015;17:234–6.
   PubMed Web of Science ®Google Scholar
• Wang Y, Chen Y, Tian F, et al. Maternal mosaicism is a significant contributor to discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing. Clin Chem 2014;60:251–9.
   PubMed Web of Science ®Google Scholar
• Choi H, Lau TK, Jiang FM, et al. Fetal aneuploidy screening by maternal plasma DNA sequencing: ‘false positive’ due to confined placental mosaicism. Prenat Diagn 2013;33:198–200.
   PubMed Web of Science ®Google Scholar
• Bianchi DW, Parsa S, Bhatt S, et al. Fetal sex chromosome testing by maternal plasma DNA sequencing: clinical laboratory experience and biology. Obstet Gynecol 2015;125:375–82.
   PubMed Web of Science ®Google Scholar
• Royal College Obstetricians and Gynaecologists. Non-invasive prenatal testing for chromosomal abnormality using maternal plasma DNA. RCOG Scientific Impact Paper No. 15, 2014.
   Google Scholar
• American College of Obstetricians and Gynecologists Committee on Genetics. Committee Opinion No. 545: Noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol 2012;120:1532–4.
   PubMed Web of Science ®Google Scholar
• Chitty LS, Finning K, Wade A, et al. Diagnostic accuracy of routine antenatal determination of fetal RHD status across gestation: population based cohort study. BMJ 2014;349:g5243.
   PubMed Web of Science ®Google Scholar
• Hill M, Finning K, Martin P, et al. Non-invasive prenatal determination of fetal sex: translating research into clinical practice. Clin Genet 2011;80:68–75.
   PubMed Web of Science ®Google Scholar
• Chitty LS, Mason S, Barrett AN, McKay F. Non-invasive prenatal diagnosis of achondroplasia and thanatophoric dysplasia: next-generation sequencing allows for a safer, more accurate, and comprehensive approach. Prenat Diagn 2015;35:656–62.
   PubMed Web of Science ®Google Scholar
• Dar P, Curnow KJ, Gross SJ, et al. Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing. Am J Obstet Gynecol 2014;211:527.e1–e17.
   PubMed Web of Science ®Google Scholar
• Chitty LS, Hill M, White H, et al. Noninvasive prenatal testing for aneuploidy-ready for prime time? Am J Obstet Gynecol 2012;206:269–75.
   PubMed Web of Science ®Google Scholar
• Chitty L, Wright D, Verhoef T, et al. Uptake, outcomes and costs of implementing non-invasive prenatal testing for Down syndrome into NHS maternity care: a prospective cohort study in eight diverse maternity units. BMJ 2016;354:i3426.
   PubMed Web of Science ®Google Scholar
• Poon LC, Nicolaides KH. First-trimester maternal factors and biomarker screening for preeclampsia. Prenat Diagn 2014;34:618–27.
   PubMed Web of Science ®Google Scholar
• Goetzinger KR, Odibo AO. Screening for abnormal placentation and adverse pregnancy outcomes with maternal serum biomarkers in the second trimester. Prenat Diagn 2014;34:635–41.
   PubMed Web of Science ®Google Scholar
• Syngelaki A, Chelemen T, Dagklis T, et al. Challenges in the diagnosis of fetal non-chromosomal abnormalities at 11–13 weeks. Prenat Diagn 2011;31:90–102.
   PubMed Web of Science ®Google Scholar
• Minear MA, Lewis C, Pradhan S, Chandrasekharan S. Global perspectives on clinical adoption of NIPT. Prenat Diagn 2015;35:959–67.
   PubMed Web of Science ®Google Scholar
• Chandrasekharan S, Minear MA, Hung A, Allyse M. Noninvasive prenatal testing goes global. Sci Transl Med 2014;6:231fs15.
   PubMed Web of Science ®Google Scholar
• UK National Screening Committee. The UK NSC recommendation on Fetal anomaly screening in pregnancy. 2016.
   Google Scholar
• Williams J III, Rad Beauchamp S, Ratousi S, et al. Utilization of noninvasive prenatal testing: Impact on referrals for diagnostic testing. Am J Obstet Gynecol 2015;213:102.e1–e6.
   PubMed Web of Science ®Google Scholar
• Larion S, Romary L, Mlynarczyk M, et al. Changes in prenatal testing trends after introduction of noninvasive prenatal testing. Obstet Gynecol 2014;123:62s–3s.
   Web of Science ®Google Scholar
• Larion MS, Warsof S, Romary L, et al. Uptake of non-invasive prenatal testing at a large academic referral center. Am J Obstet Gynecol 2014;211:651.e1–e7.
   PubMed Web of Science ®Google Scholar
• Sago H, Sekizawa A. Nationwide demonstration project of next-generation sequencing of cell-free DNA in maternal plasma in Japan: one-year experience. Prenat Diagn 2015;35:331–6.
   PubMed Web of Science ®Google Scholar
• Taylor JB, Chock VY, Hudgins L. NIPT in a clinical setting: an analysis of uptake in the first months of clinical availability. J Genet Couns 2014;23:72–8.
   PubMed Web of Science ®Google Scholar
• Warsof SL, Larion S, Abuhamad AZ. Overview of the impact of noninvasive prenatal testing on diagnostic procedures. Prenat Diagn 2015;35:972–9.
   PubMed Web of Science ®Google Scholar
• Hayden EC. Prenatal-screening companies expand scope of DNA tests. Nature 2014;507:19.
   PubMed Web of Science ®Google Scholar
• Zhao C, Tynan J, Ehrich M, et al. Detection of fetal subchromosomal abnormalities by sequencing circulating cell-free DNA from maternal plasma. Clin Chem 2015;61:608–16.
   PubMed Web of Science ®Google Scholar
• Wapner RJ, Babiarz JE, Levy B, et al. Expanding the scope of noninvasive prenatal testing: detection of fetal microdeletion syndromes. Am J Obstet Gynecol 2015;212:332.e1–e9.
   Web of Science ®Google Scholar
• Lo KK, Karampetsou E, Boustred C, et al. Limited clinical utility of non-invasive prenatal testing for subchromosomal abnormalities. Am J Hum Genet 2016;98:34–44.
   PubMed Web of Science ®Google Scholar
• Agatisa PK, Mercer MB, Leek AC, et al. A first look at women’s perspectives on noninvasive prenatal testing to detect sex chromosome aneuploidies and microdeletion syndromes. Prenat Diagn 2015;35:692–8.
   PubMed Web of Science ®Google Scholar
• van Schendel RV, Kleinveld JH, Dondorp W, et al. Attitudes of pregnant women and male partners towards non-invasive prenatal testing and widening the scope of prenatal screening. Eur J Hum Genet 2014;22:1345–50.
   PubMed Web of Science ®Google Scholar
• Bianchi DW, Chudova D, Sehnert AJ, et al. Noninvasive prenatal testing and incidental detection of occult maternal malignancies. JAMA 2015;314:162–9.
   PubMed Web of Science ®Google Scholar
• Bianchi DW. Pregnancy: prepare for unexpected prenatal test results. Nature 2015;522:29–30.
   PubMed Web of Science ®Google Scholar
• Tischler R, Hudgins L, Blumenfeld YJ, et al. Noninvasive prenatal diagnosis: pregnant women's interest and expected uptake. Prenat Diagn 2011;31:1292–9.
   PubMed Web of Science ®Google Scholar
• Lewis C, Silcock C, Chitty LS. Non-invasive prenatal testing for Down’s syndrome – pregnant women’s views and likely uptake. Public Health Genomics 2013;16:223–32.
   PubMed Web of Science ®Google Scholar
• Lewis C, Hill M, Chitty L. Women’s experience and preferences for service delivery of non-invasive prenatal testing for aneuploidy in a public health setting: a mixed methods study. PLoS One 2016;11:e0153147.
   PubMed Web of Science ®Google Scholar
• Farrell RM, Agatisa PK, Nutter B. What Women Want: Lead Considerations for Current and Future Applications of Noninvasive Prenatal Testing in Prenatal Care. Birth 2014;41:246–82.
   Web of Science ®Google Scholar
• Yi H, Hallowell N, Griffiths S, Yeung Leung T. Motivations for undertaking DNA sequencing-based non-invasive prenatal testing for fetal aneuploidy: a qualitative study with early adopter patients in Hong Kong. PLoS One 2013;8:e81794.
   PubMed Web of Science ®Google Scholar
• Chan YM, Leung WC, Chan WP, et al. Women’s uptake of non-invasive DNA testing following a high risk screening test for trisomy 21 within a publicly funded healthcare system: findings from a retrospective review. Prenat Diagn 2014;35:342–7.
   Web of Science ®Google Scholar
• Isaacs D. Moral status of the fetus: fetal rights or maternal autonomy? J Paediatr Child Health 2003;39:58–9.
   PubMed Web of Science ®Google Scholar
• Kelly SE, Farrimond HR. Non-invasive prenatal genetic testing: a study of public attitudes. Public Health Genomics 2012;15:73–81.
   PubMed Web of Science ®Google Scholar
• Michie S, Dormandy E, Marteau TM. The multi-dimensional measure of informed choice: a validation study. Patient Educ Couns 2002;48:87–91.
   PubMed Web of Science ®Google Scholar
• van den Berg M, Timmermans DR, Ten Kate LP, et al. Are pregnant women making informed choices about prenatal screening? Genet Med 2005;7:332–8.
   PubMed Web of Science ®Google Scholar
• Norton ME, Jacobsson B, Swamy GK, et al. Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med 2015;372:1589–97.
   PubMed Web of Science ®Google Scholar
• van den Heuvel A, Chitty Dormandy L, Newson E, et al. Will the introduction of non-invasive prenatal diagnostic testing erode informed choices? An experimental study of health care professionals. Patient Educ Couns 2009;78:24–8.
   PubMed Web of Science ®Google Scholar
• Silcock C, Liao L, Hill MM, Chitty LS. Will the introduction of non-invasive prenatal testing for Down's syndrome undermine informed choice? Health Expect 2014;18:1658–71.
   PubMed Web of Science ®Google Scholar
• Buchanan A, Sachs Toler AT, Tsipis J. NIPT: current utilization and implications for the future of prenatal genetic counseling. Prenat Diagn 2014;34:850–7.
   PubMed Web of Science ®Google Scholar
• Lewis C, Hill M, Skirton H, Chitty LS. Development and validation of a measure of informed choice for women undergoing non-invasive prenatal testing for aneuploidy. Eur J Hum Genet 2015;24:809–16.
   PubMed Web of Science ®Google Scholar
• Piechan JL, Hines KA, Koller D, et al. NIPT and informed consent: an assessment of patient understanding of a negative NIPT result. J Genet Couns 2016;25:1127–37.
   PubMed Web of Science ®Google Scholar
• Benn PA, Chapman AR. Practical and ethical considerations of noninvasive prenatal diagnosis. JAMA 2009;301:2154–6.
   PubMed Web of Science ®Google Scholar
• Farrimond HR, Kelly SE. Public viewpoints on new non-invasive prenatal genetic tests. Public Underst Sci 2013;22:730–44.
   PubMed Web of Science ®Google Scholar
• Vanstone M, King C, de Vrijer B, Nisker J. Non-invasive prenatal testing: ethics and policy considerations. J Obstet Gynaecol Can 2014;36:515–26.
   PubMedGoogle Scholar
• Kellogg G, Slattery L, Hudgins L, Ormond K. Attitudes of mothers of children with down syndrome towards noninvasive prenatal testing. J Genet Couns 2014;23:805–13.
   PubMed Web of Science ®Google Scholar
• Kaposy C. A disability critique of the new prenatal test for Down syndrome. Kennedy Inst Ethics J 2013;23:299–324.
   PubMed Web of Science ®Google Scholar
• Sayres LC, Allyse M, Goodspeed TA, Cho MK. Demographic and experiential correlates of public attitudes towards cell-free fetal DNA screening. J Genet Couns 2014;6:957–67.
   Web of Science ®Google Scholar
• Lewis C, Hill M, Silcock C, et al. Non-invasive prenatal testing for trisomy 21: a cross sectional survey of service users’ views and likely uptake. BJOG 2014;121:582–94.
   PubMed Web of Science ®Google Scholar
• Bianchi DW, Parker RL, Wentworth J, et al. DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med 2014;370:799–808.
   PubMed Web of Science ®Google Scholar
• Minear MA, Alessi S, Allyse M, et al. Noninvasive prenatal genetic testing: current and emerging ethical, legal, and social issues. Annu Rev Genomics Hum Genet 2015;16:369–98.
   PubMed Web of Science ®Google Scholar
• Deans Z, Clarke AJ, Newson AJ. For your interest? The ethical acceptability of using non-invasive prenatal testing to test ‘purely for information’. Bioethics 2015;29:19–25.
   PubMed Web of Science ®Google Scholar
• Hill M, Lewis C, Chitty LS. Stakeholder attitudes and needs regarding cell-free fetal DNA testing. Curr Opin Obstet Gynecol 2016;28:125–31.
   PubMed Web of Science ®Google Scholar
• Horsting JM, Dlouhy SR, Hanson K, et al. Genetic counselors’ experience with cell-free fetal DNA testing as a prenatal screening option for aneuploidy. J Genet Couns 2014;23:377–400.
   PubMed Web of Science ®Google Scholar
• Lewis C, Choudhury M, Chitty LS. ‘Hope for safe prenatal gene tests’. A content analysis of how the UK press media are reporting advances in non-invasive prenatal testing. Prenat Diagn 2014;35:420–7.
   PubMed Web of Science ®Google Scholar
• Skirton H, Goldsmith L, Jackson L, et al. Non-invasive prenatal testing for aneuploidy: a systematic review of Internet advertising to potential users by commercial companies and private health providers. Prenat Diagn 2015;35:1167–75.
   PubMed Web of Science ®Google Scholar
• Allyse M, Sayres LC, Goodspeed TA, Cho MK. Attitudes towards non-invasive prenatal testing for aneuploidy among US adults of reproductive age. J Perinatol 2014;34:429–34.
   PubMed Web of Science ®Google Scholar
• Hill M, Johnson JA, Langlois S, et al. Preferences for prenatal tests for down syndrome: an international comparison of the views of pregnant women and health professionals. Eur J Hum Genet 2016;24:968–75.
   PubMed Web of Science ®Google Scholar
• Hill M, Twiss P, Verhoef TI, et al. Non-invasive prenatal diagnosis for cystic fibrosis: detection of paternal mutations, exploration of patient preferences and cost analysis. Prenat Diagn 2015;35:950–8.
   PubMed Web of Science ®Google Scholar
• Helgeson J, Wardrop J, Boomer T, et al. Clinical outcome of subchromosomal events detected by whole-genome noninvasive prenatal testing. Prenat Diagn 2015;35:999–1004.
   PubMed Web of Science ®Google Scholar
• Lo YM, Chan KC, Sun H, et al. Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med 2010;2:61ra91.
   PubMed Web of Science ®Google Scholar